Bearish flow noted in GSK Pharma with 2,845 puts trading, or 10x expected. Most active are Sep-23 33 puts and Sep-23 36 calls, with total volume in those strikes near 2,800 contracts. The Put/Call Ratio is 2.04, while ATM IV is up over 1 point on the day. Earnings are expected on November 1st.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GSK:
- GSK announces that RSV vaccine available at all major U.S. pharmacies
- GSK sues Pfizer, alleging infringement of RSV vaccine patents
- GSK price target lowered to 1,300 GBp from 1,400 GBp at JPMorgan
- CureVac doses first patient in Phase 2 study of COVID-19 vaccine candidates
- GSK reports FDA grants expanded approval of Jemperli